Edwards Lifesciences Corporation (1EW)
MTA
Real-time Data
07:00 AM
Day's Range
77.7452 wk Range
63.84Overview - 1EW - Edwards Lifesciences Corporation
Key Statistics
Valuation
Enterprise Value
34.93B
P/E (Trailing)
‪53.40‬
PEG Ratio
‪-2.02‬
Price / Sales (TTM)
‪6.80‬
Price / Book
‪4.83‬
EV / EBITDA
‪20.47‬
Profitability
Gross Margin
‪77.46%‬
Profit Margin
‪15.43%‬
Operating Margin
‪29.83%‬
Return on Assets
‪8.36%‬
Return on Equity
‪9.17%‬
Ownership
Shares Outstanding
576.60M
Float
574.49M
Held by Insiders
‪0.19%‬
Held by Institutions
‪97.11%‬
Price stats
Beta
‪0.84‬
50-Day Avg
‪77.98‬
200-Day Avg
‪72.97‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1EW - Edwards Lifesciences Corporation
Peers - 1EW - Edwards Lifesciences Corporation
Peer Comparison
Compared with companies in Medical Devices listed on MTA.
Profile Summary - 1EW - Edwards Lifesciences Corporation
About
Edwards Lifesciences Corporation is a medical technology company focused on structural heart disease and advanced cardiovascular care. The company develops and markets transcatheter heart valve replacement systems, surgical heart valves, and repair technologies used in procedures for aortic, mitral, and tricuspid…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
